These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15229954)

  • 1. Features associated with epilepsy in the antiphospholipid syndrome.
    Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
    J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
    Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
    Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
    Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
    Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome and recurrent thrombosis in children.
    Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
    Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
    Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Traditional risk factors for cardiovascular disease in primary antiphospholipid syndrome (APS) when compared with secondary APS: a study with 96 patients].
    Ribeiro AR; Carvalho JF
    Acta Reumatol Port; 2010; 35(1):36-41. PubMed ID: 20505627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
    Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.
    Cervera R; Boffa MC; Khamashta MA; Hughes GR
    Lupus; 2009 Sep; 18(10):889-93. PubMed ID: 19671788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Lisitsyna TA; Nasonov EL
    Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.